FDA Drug Application (012616) for ALDACTAZIDE by GD SEARLE LLC

Back to FDA Applications sponsored by GD SEARLE LLC

Application Number012616
Product Number004
FormTABLET;ORAL
Dosage25MG;25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameALDACTAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; SPIRONOLACTONE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient SPIRONOLACTONE5


Back to FDA Applications sponsored by GD SEARLE LLC